Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular
Pharma
Novo's Wegovy scores key cardiovascular label expansion
The drug is the first weight loss treatment to win FDA approval to reduce the risk of severe cardio outcomes.
Zoey Becker
Mar 8, 2024 3:51pm
Novo Nordisk touts cardio outcomes win for Wegovy
Aug 8, 2023 9:49am
Novartis files FDA appeal in bid to block Entresto generics
Sep 16, 2022 11:28am
Novo Nordisk and nurses to educate T2D and ASCVD risk
Jun 30, 2022 7:35am
AZ's SGLT2 med Farxiga is hot on Jardiance's tail
May 5, 2022 10:21am
Bristol's heart med mavacamten passed muster at the FDA
Apr 29, 2022 3:33am